In this educational video, board‑certified dermatologist Dr. Jane Yoo explains exosomes—nano‑sized vesicles naturally released by cells that carry proteins, lipids, and RNA to facilitate intercellular communication in skin. She outlines how exosomes are being explored as adjuncts to aesthetic procedures such as microneedling, laser, radio‑frequency, and ultrasound, with the theory that they may enhance wound healing and modulate inflammation. Dr. Yoo also highlights emerging research into exosome effects on hair‑follicle cycling, melanocyte activity, and pigment regulation, noting that these areas remain investigational. The video details the wide variety of exosome sources—human cell cultures, platelet‑derived material, animal‑derived, and plant‑derived vesicles—and explains how source‑dependent composition leads to product variability. A clear distinction is drawn between exosomes and engineered liposomes: liposomes act as sealed delivery packages, whereas exosomes function like biological text messages delivering instructions to cells. Finally, Dr. Yoo addresses the regulatory landscape, emphasizing that no exosome‑based aesthetic product is FDA‑approved, that standards for purity, dosing, and long‑term safety are lacking, and that potential immune reactions, especially from non‑human sources, remain unresolved. She concludes that while exosomes hold promise for dermatology, clinicians should approach them with thoughtful curiosity until stronger clinical data and clearer regulations emerge.
Chapters
Hi, I'm Dr. Jane Yoo, board-certified dermatologist and Mohs surgeon. Today I want to talk about exosomes, what they are, and why they've become a widely discussed topic in aesthetic medicine. Exosomes are tiny nano-sized vesicles that are naturally released by cells. Their primary role is communication. They carry signaling molecules such as proteins, lipids, and RNA between cells, helping to coordinate normal processes like inflammation, repair, and response to stress. This type of cellular communication already occurs in healthy skin and plays a role in how skin maintains balance and responds to injury. In aesthetics, exosomes are being explored as supportive additions to procedures such as microneedling, laser treatments, radio frequency, and ultrasound. The theory is that by introducing concentrated signaling components to the skin, exosomes may help support recovery-related processes, including wound healing and inflammation. There is also growing research interest in how exosomes may influence pathways related to hair growth and pigmentation, including signals involved in follicle cycling, melanocyte function, and post-inflammatory pigment regulation, though these applications remain an active area of investigation. Importantly, exosomes are not all the same. They can be derived from a range of sources, including human cell cultures, platelet-derived materials, animal sources, and plant-based sources, and the signaling molecules they carry reflect their origin. Human-derived exosomes contain proteins, lipid, and nucleic acids involved in human cellular communication. Platelet-derived exosomes are associated with signaling pathways related to wound response and tissue repair. Plant-derived exosome-like vesicles contain plant-specific biomolecules that may interact with the skin in different ways. Because these sources differ, exosome products can vary significantly in composition, behavior, and intended use depending on how they are sourced, processed, and formulated. Now, exosomes are often grouped together with liposomes but they are not the same. Liposomes are engineered delivery systems designed to encapsulate and transport specific ingredients through the skin. An easy way to think about this is that liposomes act like sealed delivery packages carrying an ingredient from point A to point B. Exosomes, on the other hand, function more like biological text messages carrying instructions that tell cells how to respond. Unlike engineered delivery systems designed to transport specific ingredients, exosomes are bio-inspired structures that mirror how cells naturally communicate. From a formulation perspective, this places exosomes in a different category. Now, it's also important to address the regulatory landscape. No exosome-based aesthetic product is currently FDA approved in the United States. This means that there are no standardized requirements for purity, dosing, or long-term safety. Product quality can vary, and there are still unanswered questions regarding consistency, sourcing, and potential immune responses, particularly with non-human or donor-derived materials. Exosomes may play a role in the future of dermatology, but we are still in the early stages of understanding how they should be used. Until stronger clinical data and clearer regulatory guidance are available, exosome treatments should be approached with thoughtful curiosity rather than urgency.
